These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1012 related articles for article (PubMed ID: 27345938)
1. Red Blood Cell Antigen Genotyping for Sickle Cell Disease, Thalassemia, and Other Transfusion Complications. Fasano RM; Chou ST Transfus Med Rev; 2016 Oct; 30(4):197-201. PubMed ID: 27345938 [TBL] [Abstract][Full Text] [Related]
2. Red blood cell extended antigen typing in Omani patients with sickle cell disease to enhance daily transfusion practice. Breiki ASA; Kindi SA; Castilho L Immunohematology; 2024 Sep; 40(3):93-99. PubMed ID: 39373300 [TBL] [Abstract][Full Text] [Related]
3. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Aygun B; Padmanabhan S; Paley C; Chandrasekaran V Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310 [TBL] [Abstract][Full Text] [Related]
4. Red blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell disease. Boateng LA; Campbell AD; Davenport RD; Osei-Akoto A; Hugan S; Asamoah A; Schonewille H Transfusion; 2019 Jun; 59(6):2016-2022. PubMed ID: 30758856 [TBL] [Abstract][Full Text] [Related]
5. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review. Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266 [TBL] [Abstract][Full Text] [Related]
6. How do I incorporate red cell genotyping to improve chronic transfusion therapy? Van Buren NL; Gorlin JB; Corby SM; Cassidy S; FritchLilla S; Nelson SC; Westhoff CM Transfusion; 2020 Jan; 60(1):16-25. PubMed ID: 31758587 [TBL] [Abstract][Full Text] [Related]
7. RH genotypes and red cell alloimmunization rates in chronically transfused patients with sickle cell disease: A multisite study in the USA. Israelyan N; Vege S; Friedman DF; Zhang Z; Uter S; Fasano RM; Yee M; Piccone C; Kelly S; Hankins JS; Zheng Y; Westhoff CM; Chou ST Transfusion; 2024 Mar; 64(3):526-535. PubMed ID: 38289184 [TBL] [Abstract][Full Text] [Related]
8. Red blood cell alloimmunization in sickle cell disease and in thalassaemia: current status, future perspectives and potential role of molecular typing. Matteocci A; Pierelli L Vox Sang; 2014 Apr; 106(3):197-208. PubMed ID: 24117723 [TBL] [Abstract][Full Text] [Related]
9. Effects of prophylactic red blood cell (RBC) transfusion with extended antigen matching on alloimmunization in patients with Sickle Cell Disease (SCD). Leal I; Dos Santos TD; Gilli S; Castilho L Transfus Apher Sci; 2023 Dec; 62(6):103813. PubMed ID: 37743224 [TBL] [Abstract][Full Text] [Related]
10. DNA-based typing of blood groups for the management of multiply-transfused sickle cell disease patients. Castilho L; Rios M; Bianco C; Pellegrino J; Alberto FL; Saad ST; Costa FF Transfusion; 2002 Feb; 42(2):232-8. PubMed ID: 11896340 [TBL] [Abstract][Full Text] [Related]
11. Alloimmunization in sickle cell anemia in the era of extended red cell typing. O'Suoji C; Liem RI; Mack AK; Kingsberry P; Ramsey G; Thompson AA Pediatr Blood Cancer; 2013 Sep; 60(9):1487-91. PubMed ID: 23508932 [TBL] [Abstract][Full Text] [Related]
12. Genomic analyses of RH alleles to improve transfusion therapy in patients with sickle cell disease. Reid ME; Halter Hipsky C; Hue-Roye K; Hoppe C Blood Cells Mol Dis; 2014 Apr; 52(4):195-202. PubMed ID: 24309423 [TBL] [Abstract][Full Text] [Related]
13. The role of molecular immunohematology in sickle cell disease. Chou ST; Westhoff CM Transfus Apher Sci; 2011 Feb; 44(1):73-9. PubMed ID: 21277259 [TBL] [Abstract][Full Text] [Related]
14. Transfusion service knowledge and immunohaematological practices related to sickle cell disease and thalassemia. Fasano RM; Branscomb J; Lane PA; Josephson CD; Snyder AB; Eckman JR Transfus Med; 2019 Jun; 29(3):185-192. PubMed ID: 30740798 [TBL] [Abstract][Full Text] [Related]
15. The value of transfusion of phenotyped blood units for thalassemia and sickle cell anemia patients at an academic center. Hindawi S; Badawi M; Elfayoumi R; Elgemmezi T; Al Hassani A; Raml M; Alamoudi S; Gholam K Transfusion; 2020 Feb; 60 Suppl 1():S15-S21. PubMed ID: 32134130 [TBL] [Abstract][Full Text] [Related]
16. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Chou ST; Jackson T; Vege S; Smith-Whitley K; Friedman DF; Westhoff CM Blood; 2013 Aug; 122(6):1062-71. PubMed ID: 23723452 [TBL] [Abstract][Full Text] [Related]
17. RHD and RHCE genotyping by next-generation sequencing is an effective strategy to identify molecular variants within sickle cell disease patients. Dezan MR; Ribeiro IH; Oliveira VB; Vieira JB; Gomes FC; Franco LAM; Varuzza L; Ribeiro R; Chinoca KZ; Levi JE; Krieger JE; Pereira AC; Gualandro SFM; Rocha VG; Mendrone-Junior A; Sabino EC; Dinardo CL Blood Cells Mol Dis; 2017 Jun; 65():8-15. PubMed ID: 28388467 [TBL] [Abstract][Full Text] [Related]
18. DNA array analysis for red blood cell antigens facilitates the transfusion support with antigen-matched blood in patients with sickle cell disease. Ribeiro KR; Guarnieri MH; da Costa DC; Costa FF; Pellegrino J; Castilho L Vox Sang; 2009 Aug; 97(2):147-52. PubMed ID: 19392786 [TBL] [Abstract][Full Text] [Related]
19. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly asian descent. Singer ST; Wu V; Mignacca R; Kuypers FA; Morel P; Vichinsky EP Blood; 2000 Nov; 96(10):3369-73. PubMed ID: 11071629 [TBL] [Abstract][Full Text] [Related]
20. Alloimmunization in transfused patients with constitutional anemias in Norway. Furuseth MT; Alme C; Garvik LJ; Hellebostad M; Bechensteen AG; Akkök ÇA Transfus Apher Sci; 2021 Oct; 60(5):103257. PubMed ID: 34420880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]